Morgan Stanley’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.05K | Buy |
|
|||||
|
2025
Q1 | $3.19K | Sell |
|
|||||
|
2024
Q4 | $9.99K | Sell |
|
|||||
|
2024
Q3 | $51.5K | Buy |
|
|||||
|
2024
Q2 | $41.9K | Sell |
|
|||||
|
2024
Q1 | $56.6K | Sell |
|
|||||
|
2023
Q4 | $101K | Buy |
|
|||||
|
2023
Q3 | $20K | Buy |
|
|||||
|
2023
Q2 | $19.2K | Sell |
|
|||||
|
2023
Q1 | $21.3K | Buy |
|
|||||
|
2022
Q4 | $8.14K | Sell |
|
|||||
|
2022
Q3 | $19K | Buy |
|
|||||
|
2022
Q2 | $12K | Sell |
|
|||||
|
2022
Q1 | $24K | Sell |
|
|||||
|
2021
Q4 | $107K | Sell |
|
|||||
|
2021
Q3 | $161K | Sell |
|
|||||
|
2021
Q2 | $229K | Buy |
|
|||||
|
2021
Q1 | $49K | Sell |
|
|||||
|
2020
Q4 | $103K | Sell |
|
|||||
|
2020
Q3 | $141K | Sell |
|
|||||
|
2020
Q2 | $173K | Sell |
|
|||||
|
2020
Q1 | $200K | Buy |
|
|||||
|
2019
Q4 | $161K | Buy |
|
|||||
|
2019
Q3 | $55K | Sell |
|
|||||
|
2019
Q2 | $97K | Buy |
|
|||||
|
2019
Q1 | $6K | Sell |
|
|||||
|
2018
Q4 | $53K | Sell |
|
|||||
|
2018
Q3 | $386K | Buy |
|
|||||
|
2018
Q2 | $45K | Sell |
|
|||||
|
2018
Q1 | $232K | Buy |
|
|||||
|
2017
Q4 | $110K | Buy |
|
|||||
|
2017
Q3 | $105K | Sell |
|
|||||
|
2017
Q2 | $436K | Buy |
|
|||||
|
2017
Q1 | $283K | Sell |
|
|||||
|
2016
Q4 | $621K | Buy |
|
|||||
|
2016
Q3 | $218K | Buy |
|
|||||
|
2016
Q2 | $7K | Sell |
|
|||||
|
2016
Q1 | $155K | Sell |
|
|||||
|
2015
Q4 | $571K | Buy |
|
|||||
|
2015
Q3 | $131K | Sell |
|
|||||
|
2015
Q2 | $637K | Sell |
|
|||||
|
2015
Q1 | $1.46M | Sell |
|
|||||
|
2014
Q4 | $1.73M | Buy |
|
|||||
|
2014
Q3 | $736K | Buy |
|
|||||
|
2014
Q2 | $84K | Buy |
|
|||||
|
2014
Q1 | $27K | Buy |
|
|||||
|
2013
Q4 | $18K | Buy |
|